JS-38 compound
antineoplastic and a promising drug candidate in rat models in vivo and in vitro; MW: 548 Da; no further information available 2008
Also Known As:
C22H1404N2S2F6
Networked: 0
relevant articles (0 outcomes,
0 trials/studies)
Bio-Agent Context: Research Results